OCBC Lowers Gold Price Forecasts Amid Higher Yields and Weaker Demand Signals

Bearish (-0.4)Impact: Medium

Published on June 2, 2026 (3 hours ago) · By Vibe Trader

OCBC strategists Sim Moh Siong and Christopher Wong have revised their gold price forecasts downward, citing a combination of elevated oil prices, higher yields, and a more hawkish Federal Reserve stance as key factors weakening gold's near-term outlook [1]. The strategists noted that gold softened in May, attributing this to disruptions in the Hormuz region that lifted yields, supported the US dollar, and prompted a more hawkish repricing of the Fed, all of which have limited gold's safe-haven appeal [1].

Additionally, the report highlights that ETF inflows into gold have slowed, and India's recent increase in import tariffs may further weigh on physical demand at the margin [1]. OCBC suggests that for gold to regain traction in the near term, there would need to be a more favorable external backdrop, including de-escalation of US-Iran tensions, lower oil prices, softer yields, and a more dovish Fed path [1].

Despite these near-term pressures, OCBC maintains that the medium-term outlook for gold remains supported by central bank diversification, strategic allocation demand, and portfolio hedging [1]. The downward revision in gold forecasts reflects expectations for elevated oil prices to persist, continued hawkish Fed repricing, and potential softness in Indian demand [1].

CONCLUSION

OCBC's downward revision of gold price forecasts signals caution for the near term, driven by higher yields, a stronger US dollar, and weaker demand indicators. However, the medium-term outlook remains supported by central bank diversification and portfolio hedging. Investors may need to monitor macroeconomic developments and policy shifts for a potential turnaround in gold's performance.

Turn today's news into tomorrow's trade.

Try Vibe Trader Free →

Feel free to email us at team@vibetrader@gmail.com

Was this page helpful?

Related Articles

Abivax Shares Plunge Over 30% After Cancer Cases Emerge in Ulcerative Colitis Drug Trial

Abivax, a French biotechnology company, saw its shares fall as much as 32% follo...

Read more

USD/JPY Nears Two-Year High Amid BoJ Uncertainty and Intervention Fears

The USD/JPY currency pair traded marginally higher near 159.73 during the early...

Read more

Eurozone Inflation Data Delivers Few Surprises, Shifting Market Focus to Strait of Hormuz Developments

Commerzbank’s Michael Pfister highlights that the preliminary inflation figures...

Read more
OCBC Lowers Gold Price Forecasts Amid Higher Yields and Weaker Demand Signals | Vibetrader